Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Corcept Therapeutics (CORT) Return on Assets (2016 - 2026)

Corcept Therapeutics (CORT) has disclosed Return on Assets for 15 consecutive years, with 0.06% as the latest value for Q1 2026.

  • For Q1 2026, Return on Assets fell 10.0% year-over-year to 0.06%; the TTM value through Mar 2026 reached 0.06%, down 10.0%, while the annual FY2025 figure was 0.12%, 7.0% down from the prior year.
  • Return on Assets hit 0.06% in Q1 2026 for Corcept Therapeutics, down from 0.12% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.25% in Q1 2022 and bottomed at 0.06% in Q1 2026.
  • Average Return on Assets over 5 years is 0.17%, with a median of 0.17% recorded in 2024.
  • Year-over-year, Return on Assets rose 7bps in 2022 and then fell -10bps in 2026.
  • Corcept Therapeutics' Return on Assets stood at 0.18% in 2022, then fell by -4bps to 0.17% in 2023, then fell by 0bps to 0.17% in 2024, then tumbled by -31bps to 0.12% in 2025, then tumbled by -52bps to 0.06% in 2026.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.06%, 0.12%, and 0.13% for Q1 2026, Q4 2025, and Q3 2025 respectively.